IndraLab

Statements

Riluzole-, ML67-33- activates KCNK2. 1 / 1

| 1

reach

"Fluoxetine, a strong inhibitor of the riluzole-, ML67-33- and BL-1249-activated currents, also blocks TREK-1 with more potency than TREK-2, whilst TRAAK currents are essentially insensitive [XREF_BIBR, XREF_BIBR]."

29928032

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Riluzole-, ML67-33- activates KCNK2. 1 / 1

INDRA sources:

Databases

Reading